Global Valsartan Market Size, Share, and COVID-19 Impact Analysis, By Type (Tablets and Capsules), By Therapeutic Area (Hypertension, Heart Failure, Myocardial Infarction, Diabetic Nephropathy, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Drug Stores, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035

Industry: Healthcare
RELEASE DATE Feb 2026
REPORT ID SI17902
PAGES 295
REPORT FORMAT PathSoft
Request Free Sample
Description Table of Contents Scope of Report Methodology
  1. Introduction
    1. Objectives of the Study
    2. Market Definition
    3. Research Scope
  2. Research Methodology and Assumptions
  3. Executive Summary
  4. Premium Insights
    1. Porter’s Five Forces Analysis
    2. Value Chain Analysis
    3. Top Investment Pockets
      1. Market Attractiveness Analysis, By Type
      2. Market Attractiveness Analysis, By Therapeutic Area
      3. Market Attractiveness Analysis, By Distribution Channel
      4. Market Attractiveness Analysis, By Region
    4. Industry Trends
  5. Market Dynamics
    1. Market Evaluation
    2. Drivers
      1. Increasing heart disease rates, which include hypertension and heart failure
    3. Restraints
      1.  Manufacturing organizations experience strict regulatory checks and budget constraints
    4. Opportunities
      1.  Enhanced Quality Control & Regulatory Compliance
    5. Challenges
      1. Supply chain shortages
  6. Global Valsartan Market Analysis and Projection, By Type
    1. Segment Overview
    2. Tablets
    3. Capsules
  7. Global Valsartan Market Analysis and Projection, By Therapeutic Area
    1. Segment Overview
    2. Hypertension
    3. Heart Failure
    4. Myocardial Infarction
    5. Diabetic Nephropathy
    6. Others
  8. Global Valsartan Market Analysis and Projection, By Distribution Channel
    1. Segment Overview
    2. Hospital Pharmacies
    3. Retail Pharmacies
    4. Online Pharmacies
    5. Drug Stores
    6. Others
  9. Global Valsartan Market Analysis and Projection, By Regional Analysis
    1. Segment Overview
    2. North America
      1. U.S.
      2. Canada
      3. Mexico
    3. Europe
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
    4. Asia-Pacific
      1. Japan
      2. China
      3. India
    5. South America
      1. Brazil
    6. Middle East and Africa
      1. UAE
      2. South Africa
  10. Global Valsartan Market-Competitive Landscape
    1. Overview
    2. Market Share of Key Players in the Valsartan Market
      1. Global Company Market Share
      2. North America Company Market Share
      3. Europe Company Market Share
      4. APAC Company Market Share
    3. Competitive Situations and Trends
      1. Coverage Launches and Developments
      2. Partnerships, Collaborations, and Agreements
      3. Mergers & Acquisitions
      4. Expansions
  11. Company Profiles
    1. Novartis AG
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    2.   Teva Pharmaceutical Industries Ltd 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    3.  Mylan N.V. 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    4.   Hetero Labs Limited 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    5.   Sun Pharmaceutical Industries
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    6.  Lupin Pharmaceuticals Ltd.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    7.   Torrent Pharmaceuticals Limited
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    8. Aurobindo Pharma Limited
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    9.  Zydus Cadila
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    10.  Glenmark Pharmaceuticals Inc. 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    11.  AstraZeneca plc
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    12.   Sandoz International GmbH
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    13.  Dr Reddy’s Laboratories Ltd. 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    14.  Alembic Pharmaceuticals Limited
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    15. Others 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis

List of Table

  1. Global Valsartan Market, By Type, 2024-2035(USD Billion)
  2. Global Tablets, Valsartan Market, By Region, 2024-2035(USD Billion)
  3. Global Capsules, Valsartan Market, By Region, 2024-2035(USD Billion)
  4. Global Valsartan Market, By Therapeutic Area, 2024-2035(USD Billion)
  5. Global Hypertension, Valsartan Market, By Region, 2024-2035(USD Billion)
  6. Global Heart Failure, Valsartan Market, By Region, 2024-2035(USD Billion)
  7. Global Myocardial Infarction, Valsartan Market, By Region, 2024-2035(USD Billion)
  8. Global Diabetic Nephropathy, Valsartan Market, By Region, 2024-2035(USD Billion)
  9. Global Others, Valsartan Market, By Region, 2024-2035(USD Billion)
  10. Global Valsartan Market, By Distribution Channel, 2024-2035(USD Billion)
  11. Global Hospital Pharmacies, Valsartan Market, By Region, 2024-2035(USD Billion)
  12. Global Retail Pharmacies, Valsartan Market, By Region, 2024-2035(USD Billion)
  13. Global Online Pharmacies, Valsartan Market, By Region, 2024-2035(USD Billion)
  14. Global Drug Stores, Valsartan Market, By Region, 2024-2035(USD Billion)
  15. Global Others, Valsartan Market, By Region, 2024-2035(USD Billion)
  16. North America Valsartan Market, By Type, 2024-2035(USD Billion)
  17. North America Valsartan Market, By Therapeutic Area, 2024-2035(USD Billion)
  18. North America Valsartan Market, By Distribution Channel, 2024-2035(USD Billion)
  19. U.S.  Valsartan Market, By Type, 2024-2035(USD Billion)
  20. U.S.  Valsartan Market, By Therapeutic Area, 2024-2035(USD Billion)
  21. U.S.  Valsartan Market, By Distribution Channel, 2024-2035(USD Billion)
  22. Canada Valsartan Market, By Type, 2024-2035(USD Billion)
  23. Canada Valsartan Market, By Therapeutic Area, 2024-2035(USD Billion)
  24. Canada Valsartan Market, By Distribution Channel, 2024-2035(USD Billion)
  25. Mexico Valsartan Market, By Type, 2024-2035(USD Billion)
  26. Mexico Valsartan Market, By Therapeutic Area, 2024-2035(USD Billion)
  27. Mexico Valsartan Market, By Distribution Channel, 2024-2035(USD Billion)
  28. Europe Valsartan Market, By Type, 2024-2035(USD Billion)
  29. Europe Valsartan Market, By Therapeutic Area, 2024-2035(USD Billion)
  30. Europe Valsartan Market, By Distribution Channel, 2024-2035(USD Billion)
  31. Germany Valsartan Market, By Type, 2024-2035(USD Billion)
  32. Germany Valsartan Market, By Therapeutic Area, 2024-2035(USD Billion)
  33. Germany Valsartan Market, By Distribution Channel, 2024-2035(USD Billion)
  34. France Valsartan Market, By Type, 2024-2035(USD Billion)
  35. France Valsartan Market, By Therapeutic Area, 2024-2035(USD Billion)
  36. France Valsartan Market, By Distribution Channel, 2024-2035(USD Billion)
  37. U.K.  Valsartan Market, By Type, 2024-2035(USD Billion)
  38. U.K.  Valsartan Market, By Therapeutic Area, 2024-2035(USD Billion)
  39. U.K.  Valsartan Market, By Distribution Channel, 2024-2035(USD Billion)
  40. Italy Valsartan Market, By Type, 2024-2035(USD Billion)
  41. Italy Valsartan Market, By Therapeutic Area, 2024-2035(USD Billion)
  42. Italy Valsartan Market, By Distribution Channel, 2024-2035(USD Billion)
  43. Spain Valsartan Market, By Type, 2024-2035(USD Billion)
  44. Spain Valsartan Market, By Therapeutic Area, 2024-2035(USD Billion)
  45. Spain Valsartan Market, By Distribution Channel, 2024-2035(USD Billion)
  46. Asia Pacific Valsartan Market, By Type, 2024-2035(USD Billion)
  47. Asia Pacific Valsartan Market, By Therapeutic Area, 2024-2035(USD Billion)
  48. Asia Pacific Valsartan Market, By Distribution Channel, 2024-2035(USD Billion)
  49. Japan Valsartan Market, By Type, 2024-2035(USD Billion)
  50. Japan Valsartan Market, By Therapeutic Area, 2024-2035(USD Billion)
  51. Japan Valsartan Market, By Distribution Channel, 2024-2035(USD Billion)
  52. China Valsartan Market, By Type, 2024-2035(USD Billion)
  53. China Valsartan Market, By Therapeutic Area, 2024-2035(USD Billion)
  54. China Valsartan Market, By Distribution Channel, 2024-2035(USD Billion)
  55. India Valsartan Market, By Type, 2024-2035(USD Billion)
  56. India Valsartan Market, By Therapeutic Area, 2024-2035(USD Billion)
  57. India Valsartan Market, By Distribution Channel, 2024-2035(USD Billion)
  58. South America Valsartan Market, By Type, 2024-2035(USD Billion)
  59. South America Valsartan Market, By Therapeutic Area, 2024-2035(USD Billion)
  60. South America Valsartan Market, By Distribution Channel, 2024-2035(USD Billion)
  61. Brazil Valsartan Market, By Type, 2024-2035(USD Billion)
  62. Brazil Valsartan Market, By Therapeutic Area, 2024-2035(USD Billion)
  63. Brazil Valsartan Market, By Distribution Channel, 2024-2035(USD Billion)
  64. The Middle East and Africa Valsartan Market, By Type, 2024-2035(USD   Billion)
  65. The Middle East and Africa Valsartan Market, By Therapeutic Area, 2024-2035(USD   Billion)
  66. The Middle East and Africa Valsartan Market, By Distribution Channel, 2024-2035(USD Billion)
  67. UAE Valsartan Market, By Type, 2024-2035(USD Billion)
  68. UAE Valsartan Market, By Therapeutic Area, 2024-2035(USD Billion)
  69. UAE Valsartan Market, By Distribution Channel, 2024-2035(USD Billion)
  70. South Africa Valsartan Market, By Type, 2024-2035(USD Billion)
  71. South Africa Valsartan Market, By Therapeutic Area, 2024-2035(USD Billion)
  72. South Africa Valsartan Market, By Distribution Channel, 2024-2035(USD Billion)

List of Figures 

  1. Global Valsartan Market Segmentation
  2. Valsartan Market: Research Methodology
  3. Market Size Estimation Methodology: Bottom-Up Approach
  4. Market Size Estimation Methodology: Top-down Approach
  5. Data Triangulation
  6. Porter’s Five Forces Analysis
  7. Value Chain Analysis
  8. Top investment pocket in the Valsartan Market
  9. Top Winning Strategies, 2024-2035
  10. Top Winning Strategies, By Development, 2024-2035(%)
  11. Top Winning Strategies, By Company, 2024-2035
  12. Moderate Bargaining power of Buyers
  13. Moderate Bargaining power of Suppliers
  14. Moderate Bargaining power of New Entrants
  15. Low threat of Substitution
  16. High Competitive Rivalry
  17. Top Player Positioning, 2024
  18. Market Share Analysis, 2024
  19. Restraint and Drivers:  Valsartan Market
  20. Valsartan Market Segmentation, By Type
  21. Valsartan Market For Tablets, By Region, 2024-2035 ($ Billion)
  22.  Valsartan Market For Capsules, By Region, 2024-2035 ($ Billion)
  23. Valsartan Market Segmentation, By Therapeutic Area
  24.  Valsartan Market For Hypertension, By Region, 2024-2035 ($ Billion)
  25.  Valsartan Market For Heart Failure, By Region, 2024-2035 ($ Billion)
  26. Valsartan Market For Myocardial Infarction, By Region, 2024-2035 ($ Billion)
  27. Valsartan Market For Diabetic Nephropathy, By Region, 2024-2035 ($ Billion)
  28. Valsartan Market For Others, By Region, 2024-2035 ($ Billion)
  29. Valsartan Market Segmentation, By Distribution Channel
  30. Valsartan Market For Hospital Pharmacies, By Region, 2024-2035 ($ Billion)
  31. Valsartan Market For Retail Pharmacies, By Region, 2024-2035 ($ Billion)
  32. Valsartan Market For Online Pharmacies, By Region, 2024-2035 ($ Billion)
  33. Valsartan Market For Drug Stores, By Region, 2024-2035 ($ Billion)
  34. Valsartan Market For Others, By Region, 2024-2035 ($ Billion)
  35. Novartis AG: Net Sales, 2024-2035 ($ Billion)
  36. Novartis AG: Revenue Share, By Segment, 2024 (%)
  37. Novartis AG: Revenue Share, By Region, 2024 (%)
  38. Teva Pharmaceutical Industries Ltd: Net Sales, 2024-2035 ($ Billion)
  39. Teva Pharmaceutical Industries Ltd: Revenue Share, By Segment, 2024 (%)
  40. Teva Pharmaceutical Industries Ltd: Revenue Share, By Region, 2024 (%)
  41. Mylan N.V.: Net Sales, 2024-2035 ($ Billion)
  42. Mylan N.V.: Revenue Share, By Segment, 2024 (%)
  43. Mylan N.V.: Revenue Share, By Region, 2024 (%)
  44. Hetero Labs Limited: Net Sales, 2024-2035 ($ Billion)
  45. Hetero Labs Limited: Revenue Share, By Segment, 2024 (%)
  46. Hetero Labs Limited: Revenue Share, By Region, 2024 (%)
  47. Sun Pharmaceutical Industries: Net Sales, 2024-2035 ($ Billion)
  48. Sun Pharmaceutical Industries: Revenue Share, By Segment, 2024 (%)
  49. Sun Pharmaceutical Industries: Revenue Share, By Region, 2024 (%)
  50. Lupin Pharmaceuticals Ltd.: Net Sales, 2024-2035 ($ Billion)
  51. Lupin Pharmaceuticals Ltd.: Revenue Share, By Segment, 2024 (%)
  52. Lupin Pharmaceuticals Ltd.: Revenue Share, By Region, 2024 (%)
  53. Torrent Pharmaceuticals Limited: Net Sales, 2024-2035 ($ Billion)
  54. Torrent Pharmaceuticals Limited: Revenue Share, By Segment, 2024 (%)
  55. Torrent Pharmaceuticals Limited: Revenue Share, By Region, 2024 (%)
  56. Aurobindo Pharma Limited: Net Sales, 2024-2035 ($ Billion)
  57. Aurobindo Pharma Limited: Revenue Share, By Segment, 2024 (%)
  58. Aurobindo Pharma Limited: Revenue Share, By Region, 2024 (%)
  59. Zydus Cadila.: Net Sales, 2024-2035 ($ Billion)
  60. Zydus Cadila.: Revenue Share, By Segment, 2024 (%)
  61. Zydus Cadila.: Revenue Share, By Region, 2024 (%)
  62. Glenmark Pharmaceuticals Inc.: Net Sales, 2024-2035 ($ Billion)
  63. Glenmark Pharmaceuticals Inc.: Revenue Share, By Segment, 2024 (%)
  64. Glenmark Pharmaceuticals Inc.: Revenue Share, By Region, 2024 (%)
  65. AstraZeneca plc: Net Sales, 2024-2035 ($ Billion)
  66. AstraZeneca plc: Revenue Share, By Segment, 2024 (%)
  67. AstraZeneca plc: Revenue Share, By Region, 2024 (%)
  68. Sandoz International GmbH: Net Sales, 2024-2035 ($ Billion)
  69. Sandoz International GmbH: Revenue Share, By Segment, 2024 (%)
  70. Sandoz International GmbH: Revenue Share, By Region, 2024 (%)
  71. Dr Reddy’s Laboratories Ltd.: Net Sales, 2024-2035 ($ Billion)
  72. Dr Reddy’s Laboratories Ltd.: Revenue Share, By Segment, 2024 (%)
  73. Dr Reddy’s Laboratories Ltd.: Revenue Share, By Region, 2024 (%)
  74. Alembic Pharmaceuticals Limited: Net Sales, 2024-2035 ($ Billion)
  75. Alembic Pharmaceuticals Limited: Revenue Share, By Segment, 2024 (%)
  76. Alembic Pharmaceuticals Limited: Revenue Share, By Region, 2024 (%)
  77. Others: Net Sales, 2024-2035 ($ Billion)
  78. Others: Revenue Share, By Segment, 2024 (%)
  79. Others: Revenue Share, By Region, 2024 (%)

Buy Now

  • Access to only 1 person; cannot be shared; cannot be printed
  • Access for 2 to 5 users only within same department of one company
  • Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

Base Year:2024
Tables & Figures:111
Pages:295
Countries covered:15
Companies covered::17
Forecast CAGR:5.11%
Request Discount

15% Free Customization

Share your Requirements

Request Customization

We Covered in Market

  • 24/7 Analyst Support
  • Worldwide Clients
  • Tailored Insights
  • Technology Evolution
  • Competitive Intelligence
  • Custom Research
  • Syndicated Market Research
  • Market Snapshot
  • Market Segmentation
  • Growth Dynamics
  • Market Opportunities
  • Regulatory Overview
  • Innovation & Sustainability

Connect with us

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies